HB Fuller Co (NYSE:FUL) VP Sells $198,274.32 in Stock

HB Fuller Co (NYSE:FUL) VP Timothy J. Keenan sold 4,068 shares of the company’s stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $48.74, for a total transaction of $198,274.32. Following the transaction, the vice president now owns 22,472 shares of the company’s stock, valued at $1,095,285.28. The transaction was disclosed in a filing with the SEC, which is available through this link.

FUL opened at $48.29 on Friday. HB Fuller Co has a twelve month low of $39.22 and a twelve month high of $52.40. The company has a quick ratio of 1.28, a current ratio of 1.91 and a debt-to-equity ratio of 1.55. The company has a fifty day moving average of $48.94 and a 200-day moving average of $47.88. The stock has a market cap of $2.48 billion, a PE ratio of 19.16, a price-to-earnings-growth ratio of 1.59 and a beta of 1.57.

HB Fuller (NYSE:FUL) last posted its quarterly earnings data on Wednesday, January 22nd. The specialty chemicals company reported $0.88 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.92 by ($0.04). HB Fuller had a return on equity of 12.98% and a net margin of 4.52%. The firm had revenue of $739.10 million for the quarter, compared to analyst estimates of $745.62 million. During the same quarter last year, the company earned $0.90 earnings per share. The company’s quarterly revenue was down 3.8% compared to the same quarter last year. Sell-side analysts anticipate that HB Fuller Co will post 3.26 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 13th. Stockholders of record on Thursday, January 30th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend was Wednesday, January 29th. HB Fuller’s dividend payout ratio (DPR) is presently 21.62%.

FUL has been the subject of several recent research reports. Deutsche Bank upped their price target on shares of HB Fuller from $50.00 to $52.00 and gave the company a “hold” rating in a research report on Friday, January 24th. Citigroup upgraded shares of HB Fuller from a “sell” rating to a “neutral” rating and upped their price target for the company from $46.00 to $50.00 in a research report on Friday, January 24th. ValuEngine upgraded shares of HB Fuller from a “sell” rating to a “hold” rating in a research report on Tuesday, December 24th. Seaport Global Securities reiterated a “buy” rating on shares of HB Fuller in a research report on Tuesday, January 21st. Finally, Zacks Investment Research cut shares of HB Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $52.60.

Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. increased its holdings in HB Fuller by 0.8% during the second quarter. BlackRock Inc. now owns 7,608,478 shares of the specialty chemicals company’s stock worth $353,034,000 after buying an additional 57,608 shares during the last quarter. State Street Corp increased its stake in shares of HB Fuller by 1.7% in the fourth quarter. State Street Corp now owns 4,377,255 shares of the specialty chemicals company’s stock worth $225,735,000 after purchasing an additional 74,965 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of HB Fuller by 1.1% in the fourth quarter. Principal Financial Group Inc. now owns 2,071,613 shares of the specialty chemicals company’s stock worth $106,832,000 after purchasing an additional 22,928 shares in the last quarter. Champlain Investment Partners LLC increased its stake in shares of HB Fuller by 9.7% in the fourth quarter. Champlain Investment Partners LLC now owns 1,612,840 shares of the specialty chemicals company’s stock worth $83,174,000 after purchasing an additional 142,060 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in shares of HB Fuller by 28.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 917,509 shares of the specialty chemicals company’s stock worth $47,316,000 after purchasing an additional 203,776 shares in the last quarter. Institutional investors own 97.95% of the company’s stock.

About HB Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Featured Story: What is a Buy-Side Analyst?

Insider Buying and Selling by Quarter for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.